Lv31
400 积分 2023-06-20 加入
T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial
45分钟前
待确认
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies
2天前
已完结
The pancreatic cancer drug market
2个月前
已关闭
Pancreatic cancer
3个月前
已完结
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
4个月前
已完结
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
4个月前
已完结
Pancreatic Adenocarcinoma
5个月前
已完结
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
5个月前
已完结
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
5个月前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
5个月前
已完结
皖公网安备34019202002308
